Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum thyroid hormone binding inhibitor in nonthyroidal illnesses.

I J Chopra, T S Huang, A Beredo

    Metabolism: Clinical and Experimental
    |February 1, 1986
    PubMed
    Summary

    Thyroid hormone binding inhibitor (THBI) was found in most critically ill patients with nonthyroidal illnesses (NTI). This inhibitor significantly increased the dialyzable fractions of T4 and T3, indicating altered thyroid hormone transport.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Duration and dose of allopurinol needed to attain the serum urate target in gout.

    Scandinavian journal of rheumatology·2026
    Same author

    No association between vascular inflammation and estimated glomerular filtration rate in patients with rheumatoid arthritis: secondary analysis of the TARGET trial.

    Scandinavian journal of rheumatology·2025
    Same author

    Associations among temporal and large artery abnormalities on vascular ultrasound in giant cell arteritis.

    Scandinavian journal of rheumatology·2021
    Same author

    Healing of erosions in rheumatoid arthritis remains elusive: results with 24 months of the anabolic agent teriparatide.

    Scandinavian journal of rheumatology·2020
    Same author

    Patterns of prescription opioid use before total hip and knee replacement among US Medicare enrollees.

    Osteoarthritis and cartilage·2019
    Same author

    Intervals between bone mineral density testing with dual-energy X-ray absorptiometry scans in clinical practice.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019

    Area of Science:

    • Endocrinology
    • Clinical Chemistry
    • Internal Medicine

    Background:

    • Nonthyroidal illnesses (NTI) can affect thyroid hormone levels and metabolism.
    • Thyroid hormone binding inhibitor (THBI) has been implicated in altered thyroid hormone transport.

    Purpose of the Study:

    • To investigate the presence and impact of THBI in patients with NTI using a competitive ligand binding assay (CLBA).

    Main Methods:

    • Employed CLBA to detect THBI in serum ether extracts from 25 NTI patients.
    • Measured serum total T4, total T3, albumin, and dialyzable fractions of T4 (DFT4) and T3 (DFT3).
    • Analyzed correlations between THBI, clinical parameters, and thyroid hormone fractions.

    Main Results:

    • THBI detected in 60% of NTI patients (single sample) and 88% (multiple samples).

    Related Experiment Videos

  • THBI-positive patients showed significantly higher DFT4 and DFT3 compared to THBI-negative patients.
  • Ether extract of NTI serum increased DFT4 in normal serum, unlike extracts from normal subjects.

    • Conclusions:

    • THBI is prevalent in critically ill NTI patients.
    • THBI is associated with increased dialyzable fractions of T4 and T3.
    • Ether-extractable substances in NTI sera contribute to altered thyroid hormone binding and transport.